ClinicalTrials.gg

Program

JZP258

A development code. Also written as “JZP-258”, “Xywav” and “JZP258 (XYWAV)”.

Its studies are mostly in Narcolepsy · Idiopathic Hypersomnia, led by Jazz Pharmaceuticals.

Furthest: phase 4, since Feb 25, 20216 company-led studies, 1 open or runningNext primary completion: Dec 23, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Jazz Pharmaceuticals61 open or runningphase 4since Feb 25, 2021Jan 23, 2017Dec 23, 2027phase 3 · NCT07625280

Also a collaborator on its studies: jazz-pharmaceuticals-ireland-limited.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 23, 2017First study: phase 3 study in NarcolepsyFirst studyNCT03030599 · 201 enrolled · United States, Belgium, Czechia and more
  2. May 10, 2018Phase 3 study in Idiopathic HypersomniaNCT03533114 · 154 enrolled · United States, Belgium, Czechia and more
  3. Feb 25, 2021Phase 4 study in NarcolepsyNCT04794491 · 62 enrolled · United States
  4. May 12, 20232 phase 4 studiesNCT05869773, NCT05875974
  5. May 27, 2026Phase 3 study in NarcolepsyNCT07625280 · 120 planned · United States

Ahead

  1. Dec 23, 2027Primary completion: phase 3 study in NarcolepsyNCT07625280

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07625280Narcolepsy · United States3RecruitingDec 23, 2027120
NCT05875974Idiopathic Hypersomnia · United States, Canada4CompletedMar 13, 2025199
NCT05869773Narcolepsy · United States, Belgium, France and more4CompletedFeb 25, 2025155
NCT04794491Narcolepsy · United States4CompletedNov 15, 202262
NCT03533114Idiopathic Hypersomnia · United States, Belgium, Czechia and more3CompletedJun 12, 2020154
NCT03030599Narcolepsy · United States, Belgium, Czechia and more3CompletedJan 24, 2019201

How it is read

Names in the registry

  • “JZP-258”, 3 entries
  • “Xywav”, 1 entry
  • “JZP258 (XYWAV)”, 1 entry
  • “JZP258”, 1 entry

Codes read as this program: JZP258.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.